@FierceBiotech: FDA sets up roadblock for Forest, Richter, rejecting #schizophrenia drug. Story | Follow @FierceBiotech
@JohnCFierce: GlaxoSmithKline politely dumps $230M Fabry drug deal with Amicus. News | Follow @JohnCFierce
@DamianFierce: Icahn buys into Hologic; Hologic swallows 10% poison pill. Release | Follow @DamianFierce
@EmilyMFierce: Imagining the Post-Antibiotics Future. Feature (via Medium) | Follow @EmilyMFierce
> Vital Therapies is the latest in a growing list of biotechs that couldn't quite make the IPO finish line, postponing a $75 million pitch designed to fund a liver failure treatment. Story
> BioMarin Pharmaceutical ($BMRN) is teaming up with Myriad Genetics ($MYGN) to find ideal targets for an in-development cancer drug. Article
> Novartis ($NVS) is touting some positive early results for its novel H7N9 avian influenza vaccine. News
@FierceMedDev: Medtronic scores promising results for next-gen stent graft. Story | Follow @FierceMedDev
@MarkHFierce: A Belgian company snagged some new funding for an interesting ophthalmic device, tech spun out of a Seattle outfit. Item | Follow @MarkHFierce
@MichaelGFierce: FDA allows pivotal trial of Actinium's armed-antibody isotope delivery. More | Follow @MichaelGFierce
> Myriad partners up with BioMarin for cancer diagnostics. Article
> OraSure dumps Roche for Thermo Fisher in drug abuse Dx development deal. News
> Slumping Hologic downs poison pill as Icahn looms. Report
Pharma News
@FiercePharma: Wednesday's best-read story (still): Will Teva find a partner to save it from itself? More | Follow @FiercePharma
@EricPFierce: 350 sales folks get the ax as Actavis trims US force post Warner Chilcott merger. Story | Follow @EricPFierce
@CarlyHFierce: Roche's Kadcyla approved in the EU for advanced HER2-positive breast cancer. Release | Follow @CarlyHFierce
> Vimizim panel nod fuels new BioMarin buyout buzz. Story
> Forest's antipsychotic ambitions thwarted by FDA delay. More
> Pfizer whacks plant as generics eat sales. News
Vaccines News
> European Union prepares to back vaccine stability project. News
> China's climate diversity creates flu vaccination complications. More
> WHO updates malaria roadmap with 2030 vaccine goals. Article
> U.S. gathers vaccine researchers to talk bioterrorism threat Q fever. Story
> CDC to import unapproved Novartis vaccine to stem Princeton meningitis outbreak. Piece
Pharma Manufacturing News
> JLL lines up financing for $2.6B Patheon, DSM deal. More
> GE Oslo plant gets FDA OK for new heart imaging product. News
> Pfizer to close Puerto Rico plant. Story
> Actavis puts California plant on hit list. Article
> Unilife grabs $40M contract to fill Hikma injectables. More